Publication Name	World Journal of Clinical Cases
Manuscript ID	39028
Country	United States

Received	2018-03-27 06:43
Peer-Review Started	2018-03-27 12:05
To Make the First Decision	2018-05-09 04:00
Return for Revision	2018-05-09 09:07
Revised	2018-06-05 22:19
Second Decision	2018-06-25 10:11
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2018-06-27 05:45
Articles in Press	2018-06-27 05:45
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2018-07-19 02:32
Publish the Manuscript Online	2018-08-16 11:54

ISSN	2307-8960 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Editorial
Article Title	Biosimilars: Review of current applications, obstacles, and their future in medicine
Manuscript Source	Invited Manuscript
All Author List	Flyn Kaida-Yip, Kaivalya Deshpande, Trishla Saran and Dinesh Vyas
ORCID	Author(s) ORCID Number Flyn Kaida-Yip http://orcid.org/0000-0002-5651-5033 Kaivalya Deshpande http://orcid.org/0000-0003-4802-8822 Trishla Saran http://orcid.org/0000-0002-4007-2055 Dinesh Vyas http://orcid.org/0000-0002-5330-9429
Funding Agency and Grant Number
Corresponding Author	Dinesh Vyas, MD, Associate Professor, Department of Surgery, Texas Tech University, 701 West 5th Street, Suite 2263, Odessa, TX 79763, United States. dvyas@sjgh.org
Key Words	Biosimilars; Inflammatory bowel disease; Biologics; Inflammation; Drug class
Core Tip	This study elucidates the unique properties of biosimilars as a drug class and their effectiveness for inflammatory bowel conditions in lieu of first line biologics.
Publish Date	2018-08-16 11:54
Citation	Kaida-Yip F, Deshpande K, Saran T, Vyas D. Biosimilars: Review of current applications, obstacles, and their future in me­dicine. World J Clin Cases 2018; 6(8): 161-166
URL	http://www.wjgnet.com/2307-8960/full/v6/i8/161.htm
DOI	http://dx.doi.org/10.12998/wjcc.v6.i8.161

Full Article (PDF)	WJCC-6-161.pdf
Full Article (Word)	WJCC-6-161.doc
Manuscript File	39028-Review.docx
Answering Reviewers	39028-Answering reviewers.pdf
Audio Core Tip	39028-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	39028-Conflict-of-interest statement.pdf
Copyright License Agreement	39028-Copyright license agreement.pdf
Peer-review Report	39028-Peer-review(s).pdf
Scientific Misconduct Check	39028-Scientific misconduct check.pdf
Scientific Editor Work List	39028-Scientific editor work list.pdf